Biotechs Fall Apart with Dark Cross Neutral Signal

(This is an excerpt from the subscriber-only DP Weekly Wrap for Friday)Friday, the Biotechnology ETF (IBB) 20-day EMA crossed down through the

Are the Magnificent 7 Still the Kings of Wall Street?

There's no denying the strength that the mega cap growth names have exerted on the equity markets in 2024.  With their outsized